van Roon-Mom WM - Search Results

1

TBP, a polyglutamine tract containing protein, accumulates in Alzheimer's disease.

Reid SJ, van Roon-Mom WM, Wood PC, Rees MI, Owen MJ, Faull RL, Dragunow M, Snell RG. Reid SJ, et al. Brain Res Mol Brain Res. 2004 Jun 18;125(1-2):120-8. doi: 10.1016/j.molbrainres.2004.03.018. Brain Res Mol Brain Res. 2004. PMID: 15193429

2

Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice.

Kuijper EC, Overzier M, Suidgeest E, Dzyubachyk O, Maguin C, Pérot JB, Flament J, Ariyurek Y, Mei H, Buijsen RAM, van der Weerd L, van Roon-Mom W. Kuijper EC, et al. Neurobiol Dis. 2024 Jan;190:106368. doi: 10.1016/j.nbd.2023.106368. Epub 2023 Nov 29. Neurobiol Dis. 2024. PMID: 38040383 Free article.

3

Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations.

Aartsma-Rus A, van Roon-Mom W, Lauffer M, Siezen C, Duijndam B, Coenen-de Roo T, Schüle R, Synofzik M, Graessner H. Aartsma-Rus A, et al. RNA. 2023 Apr;29(4):446-454. doi: 10.1261/rna.079540.122. Epub 2023 Jan 20. RNA. 2023. PMID: 36669889 Free PMC article.

4

Amyloid beta accumulations and enhanced neuronal differentiation in cerebral organoids of Dutch-type cerebral amyloid angiopathy patients.

Daoutsali E, Pepers BA, Stamatakis S, van der Graaf LM, Terwindt GM, Parfitt DA, Buijsen RAM, van Roon-Mom WMC. Daoutsali E, et al. Front Aging Neurosci. 2023 Jan 17;14:1048584. doi: 10.3389/fnagi.2022.1048584. eCollection 2022. Front Aging Neurosci. 2023. PMID: 36733499 Free PMC article.

5

Post-mortem 7T MR imaging and neuropathology in middle stage juvenile-onset Huntington disease: A case report.

Bakels HS, van Duinen SG, de Bresser J, van Roon-Mom WMC, van der Weerd L, de Bot ST. Bakels HS, et al. Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12858. doi: 10.1111/nan.12858. Epub 2022 Nov 13. Neuropathol Appl Neurobiol. 2023. PMID: 36334065 Free PMC article. No abstract available.

6

Consensus Guidelines for the Design and In Vitro Preclinical Efficacy Testing N-of-1 Exon Skipping Antisense Oligonucleotides.

Aartsma-Rus A, Garanto A, van Roon-Mom W, McConnell EM, Suslovitch V, Yan WX, Watts JK, Yu TW. Aartsma-Rus A, et al. Nucleic Acid Ther. 2023 Jan;33(1):17-25. doi: 10.1089/nat.2022.0060. Epub 2022 Dec 13. Nucleic Acid Ther. 2023. PMID: 36516128 Free PMC article.

7

From Failure to Meet the Clinical Endpoint to U.S. Food and Drug Administration Approval: 15th Antisense Oligonucleotide Therapy Approved Qalsody (Tofersen) for Treatment of SOD1 Mutated Amyotrophic Lateral Sclerosis.

van Roon-Mom W, Ferguson C, Aartsma-Rus A. van Roon-Mom W, et al. Nucleic Acid Ther. 2023 Aug;33(4):234-237. doi: 10.1089/nat.2023.0027. Nucleic Acid Ther. 2023. PMID: 37581487 No abstract available.

8

Spinocerebellar Ataxia Type 1 Characteristics in Patient-Derived Fibroblast and iPSC-Derived Neuronal Cultures.

Buijsen RAM, Hu M, Sáez-González M, Notopoulou S, Mina E, Koning W, Gardiner SL, van der Graaf LM, Daoutsali E, Pepers BA, Mei H, van Dis V, Frimat JP, van den Maagdenberg AMJM, Petrakis S, van Roon-Mom WMC. Buijsen RAM, et al. Among authors: van roon mom wmc. Mov Disord. 2023 Aug;38(8):1428-1442. doi: 10.1002/mds.29446. Epub 2023 Jun 6. Mov Disord. 2023. PMID: 37278528

9

GLUT-1 changes in paediatric Huntington disease brain cortex and fibroblasts: an observational case-control study.

Tramutola A, Bakels HS, Perrone F, Di Nottia M, Mazza T, Abruzzese MP, Zoccola M, Pagnotta S, Carrozzo R, de Bot ST, Perluigi M, van Roon-Mom WMC, Squitieri F. Tramutola A, et al. Among authors: van roon mom wmc. EBioMedicine. 2023 Nov;97:104849. doi: 10.1016/j.ebiom.2023.104849. Epub 2023 Oct 26. EBioMedicine. 2023. PMID: 37898095 Free PMC article.

10

The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.

Alexi T, Hughes PE, van Roon-Mom WM, Faull RL, Williams CE, Clark RG, Gluckman PD. Alexi T, et al. Exp Neurol. 1999 Sep;159(1):84-97. doi: 10.1006/exnr.1999.7168. Exp Neurol. 1999. PMID: 10486177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters